메뉴 건너뛰기




Volumn 30, Issue 2, 2010, Pages 177-194

A clinical review of statins and cancer: Helpful or harmful?

Author keywords

3 hydroxy 3 methylglutaryl coenzyme A reductase inhibitors; Breast cancer; Cancer; Clinical trials; Colorectal cancer; HMG CoA; Lung cancer; Neoplasm; Pleiotropic effects; Prostate cancer; Statins

Indexed keywords

ANALGESIC AGENT; ATORVASTATIN; CERIVASTATIN; CHOLESTEROL; DOLICHOL; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MEVINOLIN; PRAVASTATIN; PROSTATE SPECIFIC ANTIGEN; ROSUVASTATIN; SIMVASTATIN;

EID: 75849124050     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.30.2.177     Document Type: Review
Times cited : (32)

References (72)
  • 1
    • 75849140253 scopus 로고    scopus 로고
    • National health statistics reports
    • summary. Available from, Accessed November 19, 2008
    • Centers for Disease Control and Prevention. National health statistics reports. National ambulatory Medicare care survey: 2006 summary. Available from http://www.cdc.gov/nchs/ data/nhsr/nhsr003.pdf. Accessed November 19, 2008.
    • (2006) National ambulatory Medicare care survey
  • 2
    • 33744490162 scopus 로고    scopus 로고
    • Drug therapy for hypercholesterolemia and dyslipidemia
    • Brunton LL, Lazo JS, Parker KL, et al, eds, 11th ed. Columbus, OH: McGraw-Hill Companies, Inc
    • Mahley RW, Bersot TP. Drug therapy for hypercholesterolemia and dyslipidemia. In: Brunton LL, Lazo JS, Parker KL, et al, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. Columbus, OH: McGraw-Hill Companies, Inc., 2006:933.
    • (2006) Goodman & Gilman's the pharmacological basis of therapeutics , pp. 933
    • Mahley, R.W.1    Bersot, T.P.2
  • 3
    • 75849149174 scopus 로고    scopus 로고
    • Agency for Healthcare Research and Quality. Statistical brief #205. Trends in statins utilization and expenditures for the U.S. civilian noninstitutionalized population, 2000 and 2005. Available from http://www.meps.ahrq.gov/mepsweb/data-files/publications/st205/stat205.pdf. Accessed November 26, 2008.
    • Agency for Healthcare Research and Quality. Statistical brief #205. Trends in statins utilization and expenditures for the U.S. civilian noninstitutionalized population, 2000 and 2005. Available from http://www.meps.ahrq.gov/mepsweb/data-files/publications/st205/stat205.pdf. Accessed November 26, 2008.
  • 4
    • 14844292583 scopus 로고    scopus 로고
    • Cancer risk among statin users: A population-based cohort study
    • Friis S, Poulsen AH, Johnsen SP, et al. Cancer risk among statin users: a population-based cohort study. Int J Cancer 2005;114:643-7.
    • (2005) Int J Cancer , vol.114 , pp. 643-647
    • Friis, S.1    Poulsen, A.H.2    Johnsen, S.P.3
  • 5
    • 24344484721 scopus 로고    scopus 로고
    • The role of statins in cancer prevention and treatment
    • Stamm JA, Ornstein DL. The role of statins in cancer prevention and treatment. Oncology (Williston Park) 2005;19:739-54.
    • (2005) Oncology (Williston Park) , vol.19 , pp. 739-754
    • Stamm, J.A.1    Ornstein, D.L.2
  • 6
    • 0001504829 scopus 로고    scopus 로고
    • Simvastatin strongly reduces the levels of Alzheimer's disease β-amyloid peptide Aβ42 and Aβ40 in vitro and in vivo
    • Fassbender K, Simons M, Bergmann C, et al. Simvastatin strongly reduces the levels of Alzheimer's disease β-amyloid peptide Aβ42 and Aβ40 in vitro and in vivo. Proc Acad Sci USA 2001;98:5856-61.
    • (2001) Proc Acad Sci USA , vol.98 , pp. 5856-5861
    • Fassbender, K.1    Simons, M.2    Bergmann, C.3
  • 7
    • 0034709764 scopus 로고    scopus 로고
    • Oral statins and increased bone-mineral density in postmenopausal women
    • Edwards CJ, Hart DJ, Spectore TD. Oral statins and increased bone-mineral density in postmenopausal women. Lancet 2000;355:2218-19.
    • (2000) Lancet , vol.355 , pp. 2218-2219
    • Edwards, C.J.1    Hart, D.J.2    Spectore, T.D.3
  • 9
    • 0033454062 scopus 로고    scopus 로고
    • Effect of the HMGCoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia
    • Glorioso N, Manunta P, Filigheddu F, et al. Effect of the HMGCoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension 1999;34:1281-6.
    • (1999) Hypertension , vol.34 , pp. 1281-1286
    • Glorioso, N.1    Manunta, P.2    Filigheddu, F.3
  • 10
    • 1242295184 scopus 로고    scopus 로고
    • Statin therapy is associated with improved survival in ischemic and nonischemic heart failure
    • Horwich TB, MacLellan WR, Fonarow GC. Statin therapy is associated with improved survival in ischemic and nonischemic heart failure. J Am Coll Cardiol 2004;43:642-8.
    • (2004) J Am Coll Cardiol , vol.43 , pp. 642-648
    • Horwich, T.B.1    MacLellan, W.R.2    Fonarow, G.C.3
  • 11
    • 0036694809 scopus 로고    scopus 로고
    • Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure
    • Horwich TB, Hamilton MA, MacLellan WR, Fonarow GC. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 2002;8:216-24.
    • (2002) J Card Fail , vol.8 , pp. 216-224
    • Horwich, T.B.1    Hamilton, M.A.2    MacLellan, W.R.3    Fonarow, G.C.4
  • 12
    • 41449093519 scopus 로고    scopus 로고
    • Effects of statins in patients with chronic kidney disease: Meta-analysis and meta-regression of randomised controlled trials
    • Strippoli GF, Navaneethan SD, Johnson DW, et al. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ 2008;336:645-51.
    • (2008) BMJ , vol.336 , pp. 645-651
    • Strippoli, G.F.1    Navaneethan, S.D.2    Johnson, D.W.3
  • 13
    • 39149086751 scopus 로고    scopus 로고
    • Cholesterol modulates cellular TGF-β responsiveness by altering TGF-β binding to TGF-β receptors
    • Chen CL, Huang SS, Huang JS. Cholesterol modulates cellular TGF-β responsiveness by altering TGF-β binding to TGF-β receptors. J Cell Physiol 2008;215:223-33.
    • (2008) J Cell Physiol , vol.215 , pp. 223-233
    • Chen, C.L.1    Huang, S.S.2    Huang, J.S.3
  • 14
    • 0034948339 scopus 로고    scopus 로고
    • Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
    • Weitz-Schmidt G, Welzenbach K, Brinkmann V, et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 2001;7:687-92.
    • (2001) Nat Med , vol.7 , pp. 687-692
    • Weitz-Schmidt, G.1    Welzenbach, K.2    Brinkmann, V.3
  • 15
    • 0038724543 scopus 로고    scopus 로고
    • Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation
    • Houten SM, Frenkel J, Waterham HR. Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation. Cell Mol Life Sci 2003;60:1118-34.
    • (2003) Cell Mol Life Sci , vol.60 , pp. 1118-1134
    • Houten, S.M.1    Frenkel, J.2    Waterham, H.R.3
  • 16
    • 0026718746 scopus 로고
    • Serum cholesterol and cancer risk: An epidemiologic perspective
    • Kritchevsky SB, Kritchevsky D. Serum cholesterol and cancer risk: an epidemiologic perspective. Annu Rev Nutr 1992;12:391-416.
    • (1992) Annu Rev Nutr , vol.12 , pp. 391-416
    • Kritchevsky, S.B.1    Kritchevsky, D.2
  • 17
    • 0025723999 scopus 로고
    • Studies on the mechanism of simvastatin-induced thyroid hypertrophy and follicular cell adenoma in the rat
    • Smith PF, Grossman SJ, Gerson RJ, et al. Studies on the mechanism of simvastatin-induced thyroid hypertrophy and follicular cell adenoma in the rat. Toxicol Pathol 1991;19:197-205.
    • (1991) Toxicol Pathol , vol.19 , pp. 197-205
    • Smith, P.F.1    Grossman, S.J.2    Gerson, R.J.3
  • 19
    • 0031081522 scopus 로고    scopus 로고
    • Synthesis and biological activity of methane sulfonyl pyrrolesubstituted 3,4-dihydroxy-6-heptanoates: A novel series of HMG-CoA reductase inhibitors
    • Watanabe M, Koike H, Ishiba T, Okada T, Seo S, Hirai K. Synthesis and biological activity of methane sulfonyl pyrrolesubstituted 3,4-dihydroxy-6-heptanoates: a novel series of HMG-CoA reductase inhibitors. Bioorg Med Chem 1997;5:437-44.
    • (1997) Bioorg Med Chem , vol.5 , pp. 437-444
    • Watanabe, M.1    Koike, H.2    Ishiba, T.3    Okada, T.4    Seo, S.5    Hirai, K.6
  • 21
    • 0032534660 scopus 로고    scopus 로고
    • Dolichol-like lipids with stimulatory effect on DNA synthesis: Substrates for protein dolichylation?
    • Wejde J, Hjertman M, Carlberg M, et al. Dolichol-like lipids with stimulatory effect on DNA synthesis: substrates for protein dolichylation? J Cell Biochem 1998;71:502-14.
    • (1998) J Cell Biochem , vol.71 , pp. 502-514
    • Wejde, J.1    Hjertman, M.2    Carlberg, M.3
  • 22
    • 0035908493 scopus 로고    scopus 로고
    • Blocking oncogenic Ras signaling for cancer therapy
    • Adjei AA. Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst 2001;93:1062-74.
    • (2001) J Natl Cancer Inst , vol.93 , pp. 1062-1074
    • Adjei, A.A.1
  • 23
    • 0242290258 scopus 로고    scopus 로고
    • p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases
    • Okumadu C, Dutta A. p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases. J Biol Chem 2003;278:43586-94.
    • (2003) J Biol Chem , vol.278 , pp. 43586-43594
    • Okumadu, C.1    Dutta, A.2
  • 24
    • 29044440878 scopus 로고    scopus 로고
    • Anti-angiogenic and anti-inflammatory effects of statins: Relevance to anti-cancer therapy
    • Dulak J, Jozkowicz A. Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy. Curr Cancer Drug Targets 2005;5:579-94.
    • (2005) Curr Cancer Drug Targets , vol.5 , pp. 579-594
    • Dulak, J.1    Jozkowicz, A.2
  • 25
    • 10744220087 scopus 로고    scopus 로고
    • Statins differentially regulate vascular endothelial growth factor in endothelial and vascular smooth muscle cells
    • Frick M, Dulak J, Cisowski J, et al. Statins differentially regulate vascular endothelial growth factor in endothelial and vascular smooth muscle cells. Atherosclerosis 2003;170:229-36.
    • (2003) Atherosclerosis , vol.170 , pp. 229-236
    • Frick, M.1    Dulak, J.2    Cisowski, J.3
  • 26
    • 75849119575 scopus 로고    scopus 로고
    • Does statin treatment alter VEGF and HIF expression in human colorectal cancer? An immunohistochemical (IHC) approach: Lower gastrointestinal 10328 [abstract]
    • De Four KJS, Paleolog E, Sandison A, Cohen P, Dawson PM. Does statin treatment alter VEGF and HIF expression in human colorectal cancer? An immunohistochemical (IHC) approach: lower gastrointestinal 10328 [abstract]. Br J Surg 2006;93:229.
    • (2006) Br J Surg , vol.93 , pp. 229
    • De Four, K.J.S.1    Paleolog, E.2    Sandison, A.3    Cohen, P.4    Dawson, P.M.5
  • 27
    • 0033826581 scopus 로고    scopus 로고
    • The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals
    • Kureishi Y, Luo Z, Shiojima I, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000;6:1004-10.
    • (2000) Nat Med , vol.6 , pp. 1004-1010
    • Kureishi, Y.1    Luo, Z.2    Shiojima, I.3
  • 28
    • 0035834823 scopus 로고    scopus 로고
    • Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins
    • Brouet A, Sonveaux P, Dessy C, et al. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circ Res 2001;89:866-73.
    • (2001) Circ Res , vol.89 , pp. 866-873
    • Brouet, A.1    Sonveaux, P.2    Dessy, C.3
  • 30
    • 2942545972 scopus 로고    scopus 로고
    • Statins prevent oxidized low-density lipoprotein- and lysophosphatidylcholineinduced proliferation of human endothelial cells
    • Schaefer CA, Kuhlmann CR, Gast C, et al. Statins prevent oxidized low-density lipoprotein- and lysophosphatidylcholineinduced proliferation of human endothelial cells. Vasc Pharmacol 2004;41:67-73.
    • (2004) Vasc Pharmacol , vol.41 , pp. 67-73
    • Schaefer, C.A.1    Kuhlmann, C.R.2    Gast, C.3
  • 31
    • 0033758875 scopus 로고    scopus 로고
    • Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation
    • Wang IK, Lin-Shiau SY, Lin JK. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation. Oncology 2000;59:245-54.
    • (2000) Oncology , vol.59 , pp. 245-254
    • Wang, I.K.1    Lin-Shiau, S.Y.2    Lin, J.K.3
  • 32
    • 0035874879 scopus 로고    scopus 로고
    • Inhibition of epidermal growth factor - induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors
    • Kusama T, Mukai M, Iwasaki T, et al. Inhibition of epidermal growth factor - induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors. Cancer Res 2001;61:4885-91.
    • (2001) Cancer Res , vol.61 , pp. 4885-4891
    • Kusama, T.1    Mukai, M.2    Iwasaki, T.3
  • 33
    • 0034614637 scopus 로고    scopus 로고
    • The hallmarks of cancer
    • Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
    • (2000) Cell , vol.100 , pp. 57-70
    • Hanahan, D.1    Weinberg, R.A.2
  • 34
    • 3042736080 scopus 로고    scopus 로고
    • Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention
    • Mo H, Elson CE. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med 2004;229:567-85.
    • (2004) Exp Biol Med , vol.229 , pp. 567-585
    • Mo, H.1    Elson, C.E.2
  • 35
    • 19844367157 scopus 로고    scopus 로고
    • Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells
    • Cafforio P, Dammacco F, Gernone A, Silvestris F. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 2005;26:883-91.
    • (2005) Carcinogenesis , vol.26 , pp. 883-891
    • Cafforio, P.1    Dammacco, F.2    Gernone, A.3    Silvestris, F.4
  • 36
    • 0033536298 scopus 로고    scopus 로고
    • Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease
    • Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999;341:70-6.
    • (1999) N Engl J Med , vol.341 , pp. 70-76
    • Pitt, B.1    Waters, D.2    Brown, W.V.3
  • 37
    • 0034633814 scopus 로고    scopus 로고
    • Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The simvastatin/enalapril coronary atherosclerosis trial (SCAT)
    • Teo KK, Burton JR, Buller CR, et al. Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: the simvastatin/enalapril coronary atherosclerosis trial (SCAT). Circulation 2000;102:1748-54.
    • (2000) Circulation , vol.102 , pp. 1748-1754
    • Teo, K.K.1    Burton, J.R.2    Buller, C.R.3
  • 38
    • 0037132607 scopus 로고    scopus 로고
    • ALLHAT Officers and Coordinators. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care
    • ALLHAT Officers and Coordinators. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care. JAMA 2002;288:2998-3007.
    • (2002) JAMA , vol.288 , pp. 2998-3007
  • 39
    • 15944410609 scopus 로고    scopus 로고
    • Intensive lipid lowering with atorvastatin in patients with stable coronary disease
    • LaRosa JC, Grudy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-35.
    • (2005) N Engl J Med , vol.352 , pp. 1425-1435
    • LaRosa, J.C.1    Grudy, S.M.2    Waters, D.D.3
  • 40
    • 27744603499 scopus 로고    scopus 로고
    • High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: The IDEAL study - a randomized controlled trial
    • Pedersen TR, Faergeman O, Kastelein JJP, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study - a randomized controlled trial. JAMA 2005;294:2437-45.
    • (2005) JAMA , vol.294 , pp. 2437-2445
    • Pedersen, T.R.1    Faergeman, O.2    Kastelein, J.J.P.3
  • 41
    • 36448964544 scopus 로고    scopus 로고
    • Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack
    • Amarenco P, Goldstein LB, Szarek M, et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack. Stroke 2007:38:3198-204.
    • (2007) Stroke , vol.38 , pp. 3198-3204
    • Amarenco, P.1    Goldstein, L.B.2    Szarek, M.3
  • 42
    • 0032572086 scopus 로고    scopus 로고
    • Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
    • Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998;279:1615-22.
    • (1998) JAMA , vol.279 , pp. 1615-1622
    • Downs, J.R.1    Clearfield, M.2    Weis, S.3
  • 43
    • 0027488722 scopus 로고
    • Coronary angiographic changes with lovastatin therapy: The monitored atherosclerosis regression study (MARS)
    • Blankenhorn DH, Azen ST, Kramsch DM, et al. Coronary angiographic changes with lovastatin therapy: the monitored atherosclerosis regression study (MARS). Ann Intern Med 1993;119:969-76.
    • (1993) Ann Intern Med , vol.119 , pp. 969-976
    • Blankenhorn, D.H.1    Azen, S.T.2    Kramsch, D.M.3
  • 44
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
    • Shepard J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-7.
    • (1995) N Engl J Med , vol.333 , pp. 1301-1307
    • Shepard, J.1    Cobbe, S.M.2    Ford, I.3
  • 45
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
    • LIPID Study Group
    • LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57.
    • (1998) N Engl J Med , vol.339 , pp. 1349-1357
  • 46
    • 10744229858 scopus 로고    scopus 로고
    • Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomized, placebo-controlled trial
    • Hallvard H, Fellstrom B, Jardine AG. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomized, placebo-controlled trial. Lancet 2003;361:2024-31.
    • (2003) Lancet , vol.361 , pp. 2024-2031
    • Hallvard, H.1    Fellstrom, B.2    Jardine, A.G.3
  • 47
    • 0037178569 scopus 로고    scopus 로고
    • Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: A randomized controlled trial
    • Serruys PW, de Feyter P, Macaya C, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;287:3215-22.
    • (2002) JAMA , vol.287 , pp. 3215-3222
    • Serruys, P.W.1    de Feyter, P.2    Macaya, C.3
  • 48
    • 22344458137 scopus 로고    scopus 로고
    • Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
    • Wanner C, Krane V, Marz W, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005;353:238-48.
    • (2005) N Engl J Med , vol.353 , pp. 238-248
    • Wanner, C.1    Krane, V.2    Marz, W.3
  • 49
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian simvastatin survival study (4S)
    • Pedersen TR, Kjekshus J, Berg K, et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994;344:1383-9.
    • (1994) Lancet , vol.344 , pp. 1383-1389
    • Pedersen, T.R.1    Kjekshus, J.2    Berg, K.3
  • 50
    • 4444252160 scopus 로고    scopus 로고
    • Mortality and incidence of cancer during 10-year follow-up of the Scandinavian simvastatin survival study (4S)
    • Strandberg TE, Pyorala K, Cook TJ, et al. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian simvastatin survival study (4S). Lancet 2004;364:771-7.
    • (2004) Lancet , vol.364 , pp. 771-777
    • Strandberg, T.E.1    Pyorala, K.2    Cook, T.J.3
  • 51
    • 0037164314 scopus 로고    scopus 로고
    • Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomized controlled trial
    • Sheperd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 2002;360:1623-30.
    • (2002) Lancet , vol.360 , pp. 1623-1630
    • Sheperd, J.1    Blauw, G.J.2    Murphy, M.B.3
  • 52
    • 0342981862 scopus 로고    scopus 로고
    • The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
    • Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
    • (1996) N Engl J Med , vol.335 , pp. 1001-1009
    • Sacks, F.M.1    Pfeffer, M.A.2    Moye, L.A.3
  • 57
    • 0034726387 scopus 로고    scopus 로고
    • 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer
    • Blais L, Desgagne A, LeLorier J. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer. Arch Intern Med 2000;160:2363-8.
    • (2000) Arch Intern Med , vol.160 , pp. 2363-2368
    • Blais, L.1    Desgagne, A.2    LeLorier, J.3
  • 58
    • 1542329169 scopus 로고    scopus 로고
    • Statin use and cancer risk in the general practice research database
    • Kaye JA, Jick H. Statin use and cancer risk in the general practice research database. Br J Cancer 2004;90:635-7.
    • (2004) Br J Cancer , vol.90 , pp. 635-637
    • Kaye, J.A.1    Jick, H.2
  • 60
    • 38449120272 scopus 로고    scopus 로고
    • The association between statins and cancer incidence in a veteran population
    • Farwell WR, Scranton RE, Lawler EV, et al. The association between statins and cancer incidence in a veteran population. J Natl Cancer Inst 2008;100:134-9.
    • (2008) J Natl Cancer Inst , vol.100 , pp. 134-139
    • Farwell, W.R.1    Scranton, R.E.2    Lawler, E.V.3
  • 61
    • 34248580619 scopus 로고    scopus 로고
    • Statins reduce the risk of lung cancer in humans: A large case-control study of U.S. veterans
    • Khurana V, Bejjanki HR, Caldito G, Owens MW. Statins reduce the risk of lung cancer in humans: a large case-control study of U.S. veterans. Chest 2007;131:1282-8.
    • (2007) Chest , vol.131 , pp. 1282-1288
    • Khurana, V.1    Bejjanki, H.R.2    Caldito, G.3    Owens, M.W.4
  • 62
    • 18744387733 scopus 로고    scopus 로고
    • The effect of statins of serum prostate specific antigen levels in a cohort of airline pilots: A preliminary report
    • Cyrus-David MS, Weinberg A, Whompson T, Kadmon D. The effect of statins of serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report. J Urol 2005;173:1923-5.
    • (2005) J Urol , vol.173 , pp. 1923-1925
    • Cyrus-David, M.S.1    Weinberg, A.2    Whompson, T.3    Kadmon, D.4
  • 63
    • 23944487796 scopus 로고    scopus 로고
    • Statins and prostate cancer risk: A case-control study
    • Shannon J, Tewoderos S, Garzotto M, et al. Statins and prostate cancer risk: a case-control study. Am J Epidemiol 2005;162:318-25.
    • (2005) Am J Epidemiol , vol.162 , pp. 318-325
    • Shannon, J.1    Tewoderos, S.2    Garzotto, M.3
  • 65
    • 33646949251 scopus 로고    scopus 로고
    • Statin use and breast cancer: Prospective results from the women's health initiative
    • Cauley JA, McTiernan A, Rodabough RJ, et al. Statin use and breast cancer: prospective results from the women's health initiative. J Natl Cancer Inst 2006;98:700-7.
    • (2006) J Natl Cancer Inst , vol.98 , pp. 700-707
    • Cauley, J.A.1    McTiernan, A.2    Rodabough, R.J.3
  • 69
    • 66949119287 scopus 로고    scopus 로고
    • Statins and the risk of colorectal carcinoma: A nested casecontrol study in veterans with diabetes
    • Hachem C, Morgan R, Johnson M, Keubeler M, El-Serag H. Statins and the risk of colorectal carcinoma: a nested casecontrol study in veterans with diabetes. Am J Gastroenterol 2009;104:1241-8.
    • (2009) Am J Gastroenterol , vol.104 , pp. 1241-1248
    • Hachem, C.1    Morgan, R.2    Johnson, M.3    Keubeler, M.4    El-Serag, H.5
  • 70
    • 65249190240 scopus 로고    scopus 로고
    • Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes
    • El-Serag HA, Johnson ML, Hachem C, Morgana RO. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology 2009;136:1601-8.
    • (2009) Gastroenterology , vol.136 , pp. 1601-1608
    • El-Serag, H.A.1    Johnson, M.L.2    Hachem, C.3    Morgana, R.O.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.